Effect of AMS initiatives on clinical outcome |
The participant learns about how AMS contributes to accurate and safer prescribing of antimicrobials, resulting in improved clinical outcomes |
Effective treatment |
Clinical outcomes (mortality and morbidity) |
Reduction of side effects |
Population specific approaches |
Effect of AMS initiatives on bacterial resistance |
The participant learns about antibiotic resistance mechanisms, including causes and extent |
Epidemiology (global) |
Genetics and mechanisms |
Relationship to antibiotic use |
Discussion of AMS initiatives like prospective audit with feedback and formulary restriction |
The participant learns how AMS reduces the spread of antimicrobial resistance |
Diagnosis of infection |
The participant learns how to accurately interpret laboratory reports in order to make clinical treatment decisions in neonates, infants, children and adolescents; |
Proper use and interpretation of bacterial Gram stain/culture, rapid and point-of-care tests, serology, and biomarkers of infection |
Establishment of standardised diagnostic criteria for specific infections |
The participant learns how to diagnose an infection in a standardised manner; |
Principles of infection management in children |
The participant learns how to make informed treatment decisions early in the course of disease in order to positively influence treatment outcomes; |
Promptly identify patients who require antibiotics |
Timely and appropriate initiation of antibiotics |
Obtain cultures before starting antibiotics |
Do not give antibiotics with overlapping activity or combinations not supported by evidence or guidelines |
The participant learns how to de-escalate antibiotic use in order to more effectively treat an infection while limiting exposure to broad-spectrum antimicrobials |
Determine and verify antibiotic allergies |
Consider local antibiotic susceptibility |
Specify expected duration of therapy based on evidence and national and hospital guidelines |
Ensure appropriate administration (intravenous versus oral) |
Give antibiotics at the right dose and interval |
Stop or de-escalate therapy promptly based on the culture and sensitivity results or establishment of an alternative diagnosis |
Reconcile and adjust antibiotics at all transitions and changes in patient’s condition |
Monitor for toxicity reliably and adjust agent and dose promptly |
Prescribing of antibiotics |
The participant learns the basics needed to prescribe antibiotics for infections caused by susceptible and resistant organisms |
Pharmacokinetics and mechanism of action of different classes of antibiotics (‘bug-drug’ coverage) |
Pharmacology and adverse effects, including risk of C. difficile infection |
Principles of empirical versus directed therapy |
Drug purchasing and dispensing costs |
Guidelines for diagnosis and management of most frequent infections in children |
|
Specific instruction for these common infections using principles outlined above |
Use of national and local guidelines and public health guidance |
Prevention of infection |
The participant learns about the importance of preventive measures to limit the development of antimicrobial resistance |
Hand hygiene |
Prudent use of catheters and devices |
Principles and duration of surgical prophylaxis |
Communication skills |
The participant learns how to apply communication techniques to talk with patients and families about prudent antibiotic use |
|